Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jill S. Lindberg"'
Publikováno v:
American Journal of Nephrology. 29:71-78
Background: National Kidney Foundation’s Kidney Disease Outcome Quality Initiative (KDOQI) guidelines offer an outline for providing standardized care for best outcomes in chronic kidney disease (CKD). It is unknown whether real-world treatment pra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68334fef26bc85963b84e359f80e5641
https://doi.org/10.1159/000151275
https://doi.org/10.1159/000151275
Autor:
Waqar H. Kazmi, Jill S. Lindberg, Vyoone Lewis, Gregorio T. Obrador, Brian J.G. Pereira, Brian Schreiber, Maya Sternberg
Publikováno v:
American Journal of Nephrology. 25:106-115
Background/Aims: Hospitalizations account for 41% of the total cost of end-stage renal disease (ESRD) care. Carnitine deficiency is common among dialysis patients, and some studies have shown improvements in anemia, and cardiac and skeletal muscle fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a18c08ec07f8abcbf496fc0367966d
https://doi.org/10.1159/000084853
https://doi.org/10.1159/000084853
Publikováno v:
Kidney International. 63:240-247
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Background Potassium citrate is commonly used in combination with a thiazide diuretic in the medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059efaebcb2ef7592f13d3fec6bd74d5
https://doi.org/10.1046/j.1523-1755.2003.00719.x
https://doi.org/10.1046/j.1523-1755.2003.00719.x
Autor:
Stewart A. Turner, Peter W. Blaisdell, William G. Goodman, Jill S. Lindberg, Sharon M. Moe, Stuart M. Sprague, Kevin J. Martin, Jack W. Coburn, Robert M. Brenner, Wei Liu
Publikováno v:
Kidney International. 63:248-254
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.BackgroundA need exists for a therapy that lowers parathyroid hormone (PTH) without increasing calcium x phosphorus in patients with second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5c06b248d627594ef4d1f3d5823222
https://doi.org/10.1046/j.1523-1755.2003.00720.x
https://doi.org/10.1046/j.1523-1755.2003.00720.x
Autor:
Jesus Navarro, Michael Suranyi, Rowan G. Walker, Chester Elias, Robert M. Brenner, Jill S. Lindberg
Publikováno v:
American Journal of Nephrology. 23:106-111
Background/Aims: Darbepoetin alfa is an erythropoiesis-stimulating protein that works via the same mechanism and has a threefold longer serum half-life than recombinant human erythropoietin (rHuEPO). The objective of this study was to evaluate extend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6451104ff3a0e84c14d30e8361290b08
https://doi.org/10.1159/000068041
https://doi.org/10.1159/000068041
Autor:
Marc I. Lorber, Marc H. Glickman, John R. Ross, Gordon K. Stokes, Samuel M. Money, Earl Schuman, Jill S. Lindberg, W. Charles Sternbergh
Publikováno v:
Journal of Vascular Surgery. 34:465-473
Objectives: The purpose of this study was to compare in a randomized, prospective, and controlled study, the performance of a multilayered, self-sealing polyurethane vascular access graft (PVAG) and expanded polytetrafluoroethylene (ePTFE) vascular a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e31cb60192c85f86b8aadaa74234e70
https://doi.org/10.1067/mva.2001.117330
https://doi.org/10.1067/mva.2001.117330
Autor:
John B. Copley, Jill S. Lindberg
Publikováno v:
Seminars in Dialysis. 14:94-98
There is no specific treatment for dialysis-related amyloidosis (DRA). Available therapy is directed at removal of large quantities of beta(2)-microglobulin (beta(2)M) and palliation of symptoms. Plasma concentrations of beta(2)M in end-stage renal d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc92a196c68d5c49e997e9c5289c975
https://doi.org/10.1046/j.1525-139x.2001.00026.x
https://doi.org/10.1046/j.1525-139x.2001.00026.x
Publikováno v:
American Journal of Kidney Diseases. 33:718-721
The National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) has set down explicit and extensive guidelines for temporary and permanent hemodialysis vascular access. It is now incumbent on the nephrologist to ensure compliance to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e173596e3eb324ad74fbf1fc4fb82b4
https://doi.org/10.1016/s0272-6386(99)70224-6
https://doi.org/10.1016/s0272-6386(99)70224-6
Autor:
John B. Copley, Jill S. Lindberg
Publikováno v:
Advances in Renal Replacement Therapy. 6:165-171
Patients with end-stage renal disease (ESRD) can benefit from exercise. At a minimum, progressive deconditioning will be prevented and cardiovascular and musculoskeletal status quo maintained, but it is also possible that physical functioning will be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d594bc1f9719a2c058bc08b1dd7eab
https://doi.org/10.1016/s1073-4449(99)70035-x
https://doi.org/10.1016/s1073-4449(99)70035-x
Autor:
Jill S. Lindberg, Melvin V. Goldblat, Jorge Arruda, James Delmez, Rebecca Sadler, Eduardo Slatopolsky, Gayithri Keshav, A. Lau, Francisco Llach
Publikováno v:
American Journal of Kidney Diseases. 32:S48-S54
In this double-blind, placebo-controlled, randomized, multicenter study, 35 patients with end-stage renal disease undergoing maintenance hemodialysis were treated three times weekly for 4 weeks with either 19-nor-1,25-dihydroxyvitamin D2 (paricalcito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104be4ede048d967a87f2407c2596710
https://doi.org/10.1053/ajkd.1998.v32.pm9808143
https://doi.org/10.1053/ajkd.1998.v32.pm9808143